B. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter
B. Braun Medical Inc. is recalling specific lots of Cefazolin Sodium injectable products because visible particulate matter was found in reserve sample units.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which per the rubric mandates a minimum score of 4 (Severe).
Plain-English summary
B. Braun Medical Inc. is recalling several injectable products, specifically Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container. The recall is due to the presence of visible particulate matter found in reserve sample units.
The affected products are sterile, single-dose, prescription-only medications intended for intravenous use only. The recall covers 136,392 units distributed nationwide, in Puerto Rico, and in Spain. Specific lot numbers and expiration dates are listed in the official recall documentation.
Healthcare providers and patients should check their inventory for the specific lot numbers and expiration dates associated with this recall. If the product is found, it should be removed from use and returned to the manufacturer or disposed of according to local regulations.
The recalled product
- Product
- CEFAZOLIN SODIUM (CEFAZOLIN SODIUM)
- Brand
- CEFAZOLIN SODIUM
- Manufacturer
- B. Braun Medical Inc
- Category
- Drug — Injectable Antibiotic
- Hazard
- Affected units
- 136,392
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot# H2S725
- H2S726
- Exp 07/14
- H3D724
- Exp 11/14
- H3E724
- Exp 12/14
- Lot# H3H507
- Exp 01/15
Distribution
Part of a larger recall action
This product is one of 12 recalled by B. Braun Medical Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same brand · CEFAZOLIN SODIUM
- HighCefazolin Sodium Injectable Recalled Nationwide for Temperature Abuse
FDA (Drugs) · 2022-06-15
- HighCefazolin Sodium injection recalled due to temperature abuse during manufacturing
FDA (Drugs) · 2022-06-15
- CriticalB. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter
FDA (Drugs) · 2014-05-07
Same manufacturer · B. Braun Medical Inc
See all →- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- ModerateB. Braun UPMC double catheter trays contain Mastisol with cracking tubing
FDA (Devices) · 2026-06-10
- ModerateB. Braun Shands kits contain Mastisol adhesive with cracking tubing
FDA (Devices) · 2026-06-10
- ModerateB. Braun spinal epidural kits contain Mastisol with cracking tubing
FDA (Devices) · 2026-06-10
- ModerateB. Braun kits contain Mastisol adhesive with potentially cracking tubing
FDA (Devices) · 2026-06-10
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26